Neuropsychopharmacology - Table of Contents alert Volume 39 Issue 1

TABLE OF CONTENTS Volume 39, Issue 1 (January 2014) In this issue Editorial Review Articles Commentaries Hot Topics Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Top Frontiers of Biomolecular Exploration in Brain Disorders Carol L Nilsson and Kathryn A Cunningham Neuropsychopharmacology 2014 39: 1-4; 10.1038/npp.2013.262 Full Text Review Articles Top Integrative Biological Analysis For Neuropsychopharmacology Mark R Emmett, Roger A Kroes, Joseph R Moskal, Charles A Conrad, Waldemar Priebe, Fernanda Laezza, Anke Meyer-Baese and Carol L Nilsson Neuropsychopharmacology 2014 39: 5-23; advance online publication, June 26, 2013; 10.1038/npp.2013.156 Abstract | Full Text Mass Spectrometry Strategies for Clinical Metabolomics and Lipidomics in Psychiatry, Neurology, and Neuro-Oncology Paul L Wood Neuropsychopharmacology 2014 39: 24-33; advance online publication, July 11, 2013; 10.1038/npp.2013.167 Abstract | Full Text Mass Spectrometry Imaging, an Emerging Technology in Neuropsychopharmacology Mohammadreza Shariatgorji, Per Svenningsson and Per E Andrén Neuropsychopharmacology 2014 39: 34-49; advance online publication, August 21, 2013; 10.1038/npp.2013.215 Abstract | Full Text Small-Volume Analysis of Cell–Cell Signaling Molecules in the Brain Elena V Romanova, Jordan T Aerts, Callie A Croushore and Jonathan V Sweedler Neuropsychopharmacology 2014 39: 50-64; advance online publication, June 10, 2013; 10.1038/npp.2013.145 Abstract | Full Text Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness Robert E McCullumsmith, John H Hammond, Dan Shan and James H Meador-Woodruff Neuropsychopharmacology 2014 39: 65-87; advance online publication, October 4, 2013; 10.1038/npp.2013.239 Abstract | Full Text An Integrated Quantitative Proteomics and Systems Biology Approach to Explore Synaptic Protein Profile Changes During Morphine Exposure Steven D Stockton, Jr and Lakshmi A Devi Neuropsychopharmacology 2014 39: 88-103; advance online publication, September 18, 2013; 10.1038/npp.2013.227 Abstract | Full Text Proteomic Approaches and Identification of Novel Therapeutic Targets for Alcoholism Giorgio Gorini, R Adron Harris and R Dayne Mayfield Neuropsychopharmacology 2014 39: 104-130; advance online publication, July 31, 2013; 10.1038/npp.2013.182 Abstract | Full Text Moonlighting Proteins and Protein–Protein Interactions as Neurotherapeutic Targets in the G Protein-Coupled Receptor Field Kjell Fuxe, Dasiel O Borroto-Escuela, Wilber Romero-Fernandez, Miklós Palkovits, Alexander O Tarakanov, Francisco Ciruela and Luigi F Agnati Neuropsychopharmacology 2014 39: 131-155; advance online publication, September 6, 2013; 10.1038/npp.2013.242 Abstract | Full Text Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance Melissa L Perreault, Ahmed Hasbi, Brian F O'Dowd and Susan R George Neuropsychopharmacology 2014 39: 156-168; advance online publication, June 18, 2013; 10.1038/npp.2013.148 Abstract | Full Text Regenerative Therapies for Central Nervous System Diseases: a Biomaterials Approach Roger Y Tam, Tobias Fuehrmann, Nikolaos Mitrousis and Molly S Shoichet Neuropsychopharmacology 2014 39: 169-188; advance online publication, September 4, 2013; 10.1038/npp.2013.237 Abstract | Full Text Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease Kaj Blennow, Harald Hampel and Henrik Zetterberg Neuropsychopharmacology 2014 39: 189-201; advance online publication, June 25, 2013; 10.1038/npp.2013.154 Abstract | Full Text Biomarkers for the Development of New Medications for Cocaine Dependence Kristopher J Bough, Shashi Amur, Guifang Lao, Scott E Hemby, Nilesh S Tannu, Kyle M Kampman, Joy M Schmitz, Diana Martinez, Kalpana M Merchant, Charles Green, Jyoti Sharma, Anne H Dougherty and F Gerard Moeller Neuropsychopharmacology 2014 39: 202-219; advance online publication, August 27, 2013; 10.1038/npp.2013.210 Abstract | Full Text Commentaries Top Revitalizing Psychiatric Therapeutics Steven E Hyman Neuropsychopharmacology 2014 39: 220-229; 10.1038/npp.2013.181 Abstract | Full Text Innovation in Therapeutics Development at the NCATS Christine M Colvis and Christopher P Austin Neuropsychopharmacology 2014 39: 230-232; 10.1038/npp.2013.247 Full Text Hot Topics Top Neurobiology of Rapid Acting Antidepressants: Role of BDNF and GSK-3β Ronald S Duman and George K Aghajanian Neuropsychopharmacology 2014 39: 233; 10.1038/npp.2013.217 Full Text Seeing the Future: Epigenetic Biomarkers of Postpartum Depression Zachary Kaminsky and Jennifer Payne Neuropsychopharmacology 2014 39: 234; 10.1038/npp.2013.238 Full Text Cell Adhesion Molecules: Druggable Targets for Modulating the Connectome and Brain Disorders? George R Uhl and Jana Drgonova Neuropsychopharmacology 2014 39: 235; 10.1038/npp.2013.240 Full Text Circuits in Sync: Decoding Theta Communication in Fear and Safety Ekaterina Likhtik and Joshua A Gordon Neuropsychopharmacology 2014 39: 235-236; 10.1038/npp.2013.228 Full Text Toward Identification of Neural Markers of Suicide Risk in Adolescents Lisa A Pan and Mary L Phillips Neuropsychopharmacology 2014 39: 236-237; 10.1038/npp.2013.233 Full Text Reduced Cocaine Reinforcement in the Male Offspring of Cocaine-Experienced Sires R Christopher Pierce and Fair M Vassoler Neuropsychopharmacology 2014 39: 238; 10.1038/npp.2013.234 Full Text De Novo Mutations in Schizophrenia Disrupt Genes Co-Expressed in Fetal Prefrontal Cortex Suleyman Gulsuner and Jon M McClellan Neuropsychopharmacology 2014 39: 238-239; 10.1038/npp.2013.219 Full Text Repetitive Transcranial Magnetic Stimulation as a Treatment for Auditory Hallucinations Iris E Sommer and Sebastian FW Neggers Neuropsychopharmacology 2014 39: 239-240; 10.1038/npp.2013.225 Full Text Error-Related Brain Activity as a Biomarker for Cocaine Relapse Reshmi Marhe and Ingmar Franken Neuropsychopharmacology 2014 39: 241; 10.1038/npp.2013.245 Full Text Parkinson's Disease Biomarkers: Resources for Discovery and Validation Mark Frasier and Un Jung Kang Neuropsychopharmacology 2014 39: 241-242; 10.1038/npp.2013.246 Full Text Neurotherapeutic Implications of Brain-Immune Interactions Jennifer C Felger and Andrew H Miller Neuropsychopharmacology 2014 39: 242-243; 10.1038/npp.2013.213 Full Text Neuronal Primary Cilia: An Underappreciated Signaling and Sensory Organelle in the Brain Jill A Green and Kirk Mykytyn Neuropsychopharmacology 2014 39: 244-245; 10.1038/npp.2013.203 Full Text When Synaptic Proteins Meet the Genome: Transcriptional Regulation in Cell Death and Plasticity by the Synapto–Nuclear Messenger Jacob Sujoy Bera and Michael R Kreutz Neuropsychopharmacology 2014 39: 245-246; 10.1038/npp.2013.204 Full Text Maintaining and Modifying Connections: Roles for Axon Guidance Cues in the Mature Nervous System Greta Thompson-Steckel and Timothy E Kennedy Neuropsychopharmacology 2014 39: 246-247; 10.1038/npp.2013.212 Full Text Functional Selectivity at GPCRs: New Opportunities in Psychiatric Drug Discovery Steven D Chang and Michael R Bruchas Neuropsychopharmacology 2014 39: 248-249; 10.1038/npp.2013.205 Full Text Obesity, Food, and Addiction: Emerging Neuroscience and Clinical and Public Health Implications Marc N Potenza Neuropsychopharmacology 2014 39: 249-250; 10.1038/npp.2013.198 Full Text Targeting Emotion Circuits with Deep Brain Stimulation in Refractory Anorexia Nervosa Nir Lipsman and Andres M Lozano Neuropsychopharmacology 2014 39: 250-251; 10.1038/npp.2013.244 Full Text Proteomic Biomarkers for Brain Disorders: Technical Considerations and Challenges Linda S Brady and William Z Potter Neuropsychopharmacology 2014 39: 252; 10.1038/npp.2013.202 Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.